{"id":"W3111705182","doi":"10.1016/j.jval.2020.08.180","title":"PCN43 Risk of Recurrence Among Patients with HR-Positive, HER2-Negative, EARLY Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Breast cancer; Meta-analysis; Hazard ratio; Anastrozole; Randomized controlled trial; Tamoxifen; Subgroup analysis; Adjuvant therapy; Adjuvant; Gynecology; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003473117,0.001670473,0.009194906,0.002279096,0.0003756172,0.001785306,0.001351763,0.00159681,0.002943745],"category_scores_gemma":[0.009518331,0.001021837,0.02203619,0.004065168,0.0004179858,0.0009491285,0.001071173,0.001617078,0.00028316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001008048,"about_ca_system_score_gemma":0.001616275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008222819,"about_ca_topic_score_gemma":0.02305654,"domain_scores_codex":[0.9980045,0.0006751054,0.0006186236,0.0003468318,0.0002413781,0.0001135299],"domain_scores_gemma":[0.9965286,0.002378097,0.0005929173,0.0001560712,0.0002670724,0.00007732506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002762591,0.0000427045,0.01186618,0.3006624,0.6562031,0.0001752595,0.0001018997,0.0004882841,0.000400483,0.0001446792,0.001344864,0.02580758],"study_design_scores_gemma":[0.0004931048,0.0001362907,0.008664189,0.01115602,0.9769033,0.0001036277,0.00005190877,0.00011883,0.00008652298,0.0001803036,0.002076628,0.00002932004],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004370027,0.9946597,0.0002317658,0.00009160804,0.00008745527,0.00004284653,0.0003634384,0.00001066582,0.0001424264],"genre_scores_gemma":[0.1549516,0.841733,0.001089124,0.0007472963,0.0002204122,0.0001785817,0.0006743493,0.00001854833,0.0003872214],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009194906,"threshold_uncertainty_score":0.01836783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03763970652950111,"score_gpt":0.3181948405284842,"score_spread":0.2805551339989831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}